Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYBB | P04839 | 6/20 | 0.54 |
| ▸ | NOX4 | Q9NPH5 | 6/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MAPK3 | P27361 | 5/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12960511 | 0.85 | KDR (0.61) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL3706296 | 0.85 | KDR (0.61) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL3706297 | 0.85 | KDR (0.61) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL21037849 | 0.83 | CYBB (0.53) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL24981920 | 0.82 | CYBB (0.51) | CYBBNOX4KMT2AMAPTMAPK1 | |
| SCHEMBL21037413 | 0.81 | L3MBTL1 (0.41) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL21217202 | 0.80 | KMT2A (0.64) | L3MBTL1KMT2AKDRMAPTKDM4E | |
| SCHEMBL21160616 | 0.80 | CYBB (0.43) | CYBBNOX4L3MBTL1KMT2AKDR | |
| SCHEMBL21217195 | 0.80 | KMT2A (0.61) | L3MBTL1KMT2AKDRMAPTKDM4E | |
| SCHEMBL24982350 | 0.76 | CYBB (0.45) | CYBBNOX4KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-06-20 | — | — | US | disclosed |
| EP-3489324-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | East China University of Science and Technology (CN) | 2019-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | HNRNPF, HNRNPUL2, RAB5IF | CYBB 3632/4885NOX4 4489/4885L3MBTL1 616/4885 |
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | HNRNPF, HNRNPUL2, RAB5IF | CYBB 3632/4885NOX4 4489/4885L3MBTL1 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.